Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers

Mazurek, 2002, Activation of human MutS Homologs by 8-Oxo-guanine DNA damage, J. Biol. Chem., 277, 8260, 10.1074/jbc.M111269200 Klungland, 1999, Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage, Proc. Natl. Acad. Sci. U. S. A., 96, 13300, 10.1073/pnas.96.23.13300 Cooke, 2000, Urinary 8-oxo-2′-deoxyguanosine-source, significance and supplements, Free Radic. Res., 32, 381, 10.1080/10715760000300391 Helbock, 1999, 8-Hydroxydeoxyguanosine and 8-hyroxyguanine as biomarkers of oxidative DNA damage, Methods Enzymol., 300, 156, 10.1016/S0076-6879(99)00123-8 Poulsen, 1998, Role of oxidative DNA damage in cancer initiation and promotion, Eur. J. Cancer Prev., 7, 9 Toyokuni, 1995, Persistent oxidative stress in cancer, FEBS Lett., 358, 1, 10.1016/0014-5793(94)01368-B Szatrowski, 1991, Production of large amounts of hydrogen peroxide by human tumor cells, Cancer Res., 51, 794 Foksinski, 2000, The concentration of typical biomarker of oxidative stress 8-hydroxy-2′-deoxyguanosine is higher in uterine myomas than in control tissues and correlates with the size of the tumor, Free Radic. Biol. Med., 29, 597, 10.1016/S0891-5849(00)00358-0 Matsui, 2000, Increased formation of oxidative DNA damage, 8-hydroxy-2′deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 ad COMT genotypes, Cancer Lett., 151, 87, 10.1016/S0304-3835(99)00424-3 Djuric, 1996, Concentrations of 5-hydroxymethyl-2′-deoxyuridine in DNA from blood as a marker of breast cancer, Cancer, 77, 691, 10.1002/(SICI)1097-0142(19960215)77:4<691::AID-CNCR15>3.0.CO;2-W Erhola, 1997, Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2′-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment, FEBS Lett., 409, 287, 10.1016/S0014-5793(97)00523-1 Wood SG, Gedik CM, Vaughan NJ, Collins AR. Measurement of 8-Oxo-deoxyguanosine in lymphocytes, cultured cells and tissue samples by HPLC with electrochemical detection. In: Bamett YA, Bamett CR, editors. Methods in molecular medicine, vol. 38. Aging methods and protocols. Humana Press, Totowa, NJ. Yin, 1995, Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA, Free Radic. Biol. Med., 18, 1023, 10.1016/0891-5849(95)00003-G Senapathy, 1985, Mechanism of coupling periodate-oxidized nucleosides to proteins, FEBS Lett., 190, 337, 10.1016/0014-5793(85)81314-4 Gackowski, 2001, 8-oxo- 7,8-dihydroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanosine concentrations in human urine do not depend on diet, Free Radic. Res., 35, 825, 10.1080/10715760100301321 Rozalski, 2002, The concentration of 8-hydroxyguanine, a possible repair product of oxidative DNA damage, is higher in urine of cancer patients than in control subjects, Cancer Epidemiol. Biomark. Prev., 11, 1072 Weimann, 2002, Quantification of 8-oxo-guanine and guanine as the nucleobase, nucleoside and deoxynucleoside forms in human urine by high-performance liquid chromatography-electrospray tandem mass spectrometry, Nucleic Acids Res., 30, E7, 10.1093/nar/30.2.e7 Poulsen, 1998, Role of oxidative DNA damage in cancer initiation and promotion, Eur. J. Cancer Prev., 7, 9 Kojda, 1999, Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure, Cardiovasc. Res., 43, 562, 10.1016/S0008-6363(99)00169-8